Skip to NavigationSkip to content

News

The Brussels-based pharmaceutical company UCB has announced that the European Medicines Agency (EMA) has approved a label extension for Cimzia (...
Roche has unveiled new Phase 3 data on Tecentriq in combination with chemotherapy as a first-line treatment, confirming that it met its co-primary...
It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have received approval in...
Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio, has been approved for the treatment of patients with moderately to...
A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham litigation in an effort...
A swathe of new drug approvals in HIV, multiple sclerosis and lung cancer, J&J's second-in-command to step down, and Amgen's biosimilar of J&...
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.
The European Commission has approved Pfizer's Xeljanz in combination with methotrexate for the treatment of active psoriatic arthritis in adult...
Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s humanised...
It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon has finally made an official move...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches